Cohort Profile: The epidemiology of chronic diseases and multimorbidity. The EpiChron cohort study
Prados-Torres, A. ; Poblador-Plou, B. ; Gimeno-Miguel, A. ; Calderón-Larrañaga, A. ; Poncel-Falcó, A. ; Gimeno-Feliú, L.A. (Universidad de Zaragoza) ; González-Rubio, F. ; Laguna-Berna, C. ; Marta-Moreno, J. (Universidad de Zaragoza) ; Clerencia-Sierra, M. ; Aza-Pascual-Salcedo, M. ; Bandrés-Liso, A.C. ; Coscollar-Santaliestra, C. ; Pico-Soler, V. ; Abad-Díez, J.M.
Resumen: Why was the cohort set up?
Greater life expectancy in Europe over the past few decades has been translated into an increasing burden of chronic diseases that accumulate as the population ages, whereas acute infectious diseases have been progressively pushed into the background. The incidence of conditions such as hypertension, obesity and asthma has increased dramatically worldwide, and cancer, diabetes and respiratory and cardiovascular diseases are responsible for almost 70% of global deaths.
Concurrently, the prevalence of multimorbidity (as of people affected by more than one chronic disorder) is also increasing and appears as the most common chronic condition at present.
Multimorbidity affects almost 3 in 4 individuals aged 65 years and older, although it represents a problem not only for the elderly but also for adult and even young populations, at whom prevention strategies should aim. People affected by multimorbidity often experience fragmentation of care, greater and inadequate use of health services and polypharmacy, which in turn may increase the risk of low adherence and adverse drug reactions.
All of this leads to individuals’ quality of life deterioration and higher risk of mortality. Besides, handling patients with multimorbidity represents a daily challenge for physicians and health systems...
Idioma: Inglés
DOI: 10.1093/ije/dyx259
Año: 2018
Publicado en: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 47, 2 (2018), 382e-384e
ISSN: 0300-5771
Factor impacto JCR: 7.339 (2018)
Categ. JCR: PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH rank: 6 / 185 = 0.032 (2018) - Q1 - T1
Factor impacto SCIMAGO: 4.187 - Medicine (miscellaneous) (Q1) - Epidemiology (Q1)
Financiación: info:eu-repo/grantAgreement/ES/FEDER/POCTEFA
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI11-01126
Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial.
Exportado de SIDERAL (2020-01-08-09:28:14)
Visitas y descargas
Greater life expectancy in Europe over the past few decades has been translated into an increasing burden of chronic diseases that accumulate as the population ages, whereas acute infectious diseases have been progressively pushed into the background. The incidence of conditions such as hypertension, obesity and asthma has increased dramatically worldwide, and cancer, diabetes and respiratory and cardiovascular diseases are responsible for almost 70% of global deaths.
Concurrently, the prevalence of multimorbidity (as of people affected by more than one chronic disorder) is also increasing and appears as the most common chronic condition at present.
Multimorbidity affects almost 3 in 4 individuals aged 65 years and older, although it represents a problem not only for the elderly but also for adult and even young populations, at whom prevention strategies should aim. People affected by multimorbidity often experience fragmentation of care, greater and inadequate use of health services and polypharmacy, which in turn may increase the risk of low adherence and adverse drug reactions.
All of this leads to individuals’ quality of life deterioration and higher risk of mortality. Besides, handling patients with multimorbidity represents a daily challenge for physicians and health systems...
Idioma: Inglés
DOI: 10.1093/ije/dyx259
Año: 2018
Publicado en: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY 47, 2 (2018), 382e-384e
ISSN: 0300-5771
Factor impacto JCR: 7.339 (2018)
Categ. JCR: PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH rank: 6 / 185 = 0.032 (2018) - Q1 - T1
Factor impacto SCIMAGO: 4.187 - Medicine (miscellaneous) (Q1) - Epidemiology (Q1)
Financiación: info:eu-repo/grantAgreement/ES/FEDER/POCTEFA
Financiación: info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI11-01126
Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)
Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial.Exportado de SIDERAL (2020-01-08-09:28:14)
Enlace permanente:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Artículos
Registro creado el 2018-06-18, última modificación el 2020-01-08